Jeanette Peter, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 2917 Via Rivera, Palos Verdes Estates, CA 90274 Phone: 310-265-6626 |
News Archive
Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery.
deCODE genetics, Inc. today announced that it has completed the previously-announced sale of its Iceland-based subsidiary deCODE genetics ehf (also known as Islensk erfdagreining) and its drug discovery and development programs to Saga Investments LLC, a private company. The sale followed approval by the U.S. Bankruptcy Court for the District of Delaware in deCODE genetics Inc.'s ongoing proceeding under Chapter 11 of the U.S. Bankruptcy Code.
It is estimated that more than 1 billion individuals worldwide in 2005 had presbyopia, or age-related difficulty in seeing objects nearby, with an estimated 410 million with the condition unable to perform tasks requiring near vision, according to a report in the December issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
Despite the importance of site investigators to the success of multicentre clinical trials, inadequate public information is available about their recruitment performance. In this week's PLoS Medicine, Rafael Dal-R- and colleagues argue that that sponsors should disclose the recruitment targets of all site investigators on ClinicalTrials.gov before a trial starts, as well as their final recruitment.
› Verified 8 days ago